PRICING · MEN · TESTOSTERONE

How Much Does TRT Cost? The Monthly Price, the Lab Bill and the First-Year Total

Testosterone therapy at ACT 2 Health costs $249 for the first month, which covers the new-patient evaluation and the baseline lab panel, then $149 a month after that, with the clinical care and the medication included; a 3-month supply is $450. Follow-up lab work is billed separately: the comprehensive panel is $199 each time it is drawn after the first. Assuming one follow-up panel, a first year comes to $2,087.

This page works through that figure line by line. The full catalog is on pricing; whether testosterone is right for you is answered on the low testosterone page.

See if you're eligibleA short, confidential online assessment. Reviewed by a clinician.

Medically reviewed by Benjamin H. Krasne, M.D. —

Board-certified physician bringing a rigorous, science-driven lens to longevity medicine and weight management. Full bio

What ACT 2 charges for testosterone therapy

TreatmentOptionPriceHow it is billed
Testosterone Replacement Therapy (TRT)New patient$249First month, including the new-patient evaluation
Refill$149Each month after the first
3 months$450Once for 3 months ($150/month)
Enclomiphene / DHEA / Boron / Pregnenolone ODT1 month$129Monthly
3 months$349Once for 3 months ($116/month)
Comprehensive Lab PanelOne-time$199One-time

The testosterone program is a subscription you can cancel at any time. The first month is $249 because it carries the new-patient workup and the build of your plan, including the baseline lab panel and the live visit with a clinician that a controlled substance requires before any prescription. Every month after is a $149 refill that covers ongoing medication and monitoring, or you can pay $450 for a 3-month supply, which works out to $150 a month: about the same as the refill rate rather than a discount on it. Where medically appropriate, the prescription is written for six months with monthly refills. The program is priced as a program, not per preparation: the clinician selects the route during your visit, and the men's TRT program explains how that choice is made.

Enclomiphene ODT is a separate line at $129 a month, or $349 for a 3-month supply ($116 a month), with no separate first-month rate and the lab panel included. Which men it suits is covered in TRT vs enclomiphene; this page only prices it.

The comprehensive lab panel is $199 per draw when it is ordered on its own. The baseline panel is included in the testosterone program's first month and in the enclomiphene price; follow-up panels are billed at that rate. The comprehensive panel page lists what it measures, including hormones and blood count.

The assessment and the clinician's eligibility review are free. There is no membership fee, and prices are the same in every state. Lab testing is not currently available in New York, New Jersey or Rhode Island, which matters here because testosterone is not started without labs; there, you can upload recent bloodwork from your own physician instead; state availability has the detail.

What does TRT cost in the first year?

The monthly price is only part of it. The lab schedule sets the rest, and it comes from the Endocrine Society's 2018 clinical practice guideline on testosterone therapy in men with hypogonadism.

Before treatment, the guideline asks for total testosterone measured on two separate mornings, because a single low result is not a diagnosis. After it starts, testosterone and hematocrit are measured at 3 to 6 months, then at 12 months and annually. Hematocrit is checked at baseline too, because testosterone can thicken the blood.

LineWhenCost
New-patient month, baseline panel includedMonth 1$249
RefillsMonths 2 to 12$1,639
Follow-up comprehensive panelMonth 3 to 6$199
First-year total$2,087

The assumption, stated plainly: twelve billed months of the testosterone program paid monthly, the baseline comprehensive panel that comes with the first month, and one follow-up comprehensive panel at the 3-to-6-month check, with nothing else added. Spread across twelve months, that is roughly $174 a month.

The same arithmetic for enclomiphene, whose price includes the baseline panel, with one follow-up panel, is $1,747 paid monthly or $1,595 as four 3-month supplies. Its monitoring is set by your clinician rather than by the testosterone guideline, so treat that figure as a comparison of prices only.

What makes the number go up or down

A confirming morning test. If your first panel shows a low or borderline testosterone, the second morning measurement the guideline requires is another draw before anything is prescribed. If it is a second comprehensive panel, add $199. Getting the test right explains why the timing matters.

The 12-month check landing inside year one. The guideline's 12-month testosterone and hematocrit check falls right at the year's edge. If your clinician draws it in month 12, a second follow-up panel brings the year to $2,286.

A result that needs a recheck. A rising hematocrit, a PSA change or a level outside the target range usually means a repeat draw sooner than planned.

Stopping or pausing. The program is a subscription you can cancel at any time, so a year you stop in month five is five months of program charges, not twelve; a 3-month supply is paid for in full when it is ordered. Cancellation terms are shown at enrollment. Stopping testosterone is a clinical decision as well as a billing one; stopping TRT covers why.

The welcome offer. New patients get 10% off the first order through the welcome page. It does not apply to lab panels. Shipping and taxes, where they apply, are shown before you pay.

Does insurance cover TRT?

Often, yes, if you meet the plan's criteria, so someone with good coverage may pay less through insurance than through ACT 2. Testosterone replacement is FDA-approved for diagnosed hypogonadism, and generic testosterone products sit on many drug lists.

What insurers require is fairly consistent. Cigna's published drug coverage policy for oral, topical and nasal testosterone requires prior authorization and, for a new start, all of the following: persistent symptoms of androgen deficiency, two pretreatment testosterone measurements taken in the early morning on two separate days, and both results below the laboratory's normal range, with documentation. Aetna's policy for testosterone cypionate injections asks for at least two confirmed low morning levels before therapy starts. Both track the medical standard: the American Urological Association defines low testosterone by a total testosterone below its guideline cutoff, measured on two separate early mornings, together with symptoms.

Plans also use step therapy. Cigna's policy, on some drug lists, asks a patient to have tried one or two generic topical testosterone products before it covers a branded oral capsule. Medicare drug plans can apply the same tools: prior authorization, step therapy and quantity limits.

ACT 2 does not bill insurance, Medicare or Medicare Advantage for treatments or lab panels. Enclomiphene ODT is compounded, and compounded drugs are not FDA-approved, so it is not a product a pharmacy benefit is built to cover. If you have coverage and meet the criteria, price the insured route first. The pricing and insurance FAQ covers HSA and FSA use; so does the FSA and HSA year-end guide.

Questions

Frequently asked questions

  • Without insurance, testosterone therapy at ACT 2 Health costs $249 for the first month, including the baseline lab panel, and $149 a month after, with the clinician's care and the medication included; a 3-month supply is $450. Follow-up lab work is separate at $199 per comprehensive panel. With one follow-up panel, a first year comes to $2,087.

  • The first month of TRT costs more because it covers the new-patient evaluation: the baseline lab panel, the workup, the live clinician visit required before a controlled substance can be prescribed, and the build of your plan. From the second month the program drops to the $149 refill rate, which covers ongoing medication and monitoring once you are established.

  • The baseline panel is. The $249 first month of the testosterone program at ACT 2 Health includes the comprehensive lab panel that testosterone is not started without. Follow-up panels are billed separately at $199 each, and the Endocrine Society guideline calls for checks at 3 to 6 months and then annually, so budget for at least one further panel in year one.

  • Enclomiphene ODT costs $129 a month at ACT 2 Health, or $349 for a 3-month supply, with no separate new-patient rate and the lab panel included. Follow-up panels are $199 each, so twelve months paid monthly with one follow-up panel comes to $1,747. It is a compounded preparation suited to a specific group of men; your clinician decides whether it fits.

  • Insurance often covers testosterone therapy for diagnosed hypogonadism, but usually only with prior authorization. Published payer policies typically require symptoms plus two low early-morning testosterone results on separate days, documented before treatment starts. Some plans also require trying a generic product first. ACT 2 Health does not bill insurance, so if you qualify under your plan, the insured route may cost you less.

  • Yes. The second year of TRT at ACT 2 Health costs less because the new-patient charge only applies once. Twelve refills at $149 plus one annual comprehensive panel comes to $1,987. More draws than that, for example to recheck hematocrit after a dose change, add $199 each.

Your next step

Where this fits in your plan

Cost is the last question, not the first. The first is whether a low result is real: what testosterone levels by age actually tell you. How the program runs is on the men's TRT program. If fertility in the next few years matters, read TRT vs enclomiphene before comparing prices, because it changes which line of the table applies to you. And because the first-year total can turn into a decade of monthly bills, read whether TRT is lifelong — for many men it depends on the cause.

The prices here are confirmed at your eligibility review, before you are charged anything.

We measure first. Then we act.

References

  1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 2018 (full text, monitoring table). https://academic.oup.com/jcem/article/103/5/1715/4939465
  2. Endocrine Society. Testosterone Therapy in Men With Hypogonadism: Clinical Practice Guideline recommendations, 2018. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy
  3. American Urological Association. Evaluation and Management of Testosterone Deficiency: AUA Guideline, 2018, amended 2024. https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
  4. Cigna Healthcare. Drug Coverage Policy IP0350: Testosterone (Oral, Topical, and Nasal) Products, effective 2026. https://static.cigna.com/assets/chcp/pdf/coveragePolicies/pharmacy/ip_0350_coveragepositioncriteria_testosterone_oral_top_nasal.pdf
  5. Aetna. Testosterone Cypionate Injections, Medical Clinical Policy Bulletin 1014. https://www.aetna.com/cpb/medical/data/1000_1099/1014.html
  6. Medicare.gov. Drug plan rules: prior authorization, step therapy and quantity limits. Centers for Medicare & Medicaid Services. https://www.medicare.gov/health-drug-plans/part-d/what-drug-plans-cover/plan-rules
  7. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  8. MedlinePlus. Testosterone Levels Test. National Library of Medicine. https://medlineplus.gov/lab-tests/testosterone-levels-test/

How we write and review our content

ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.

Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.

Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.

Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.

Prices shown are current catalog prices and are confirmed at your eligibility review; first-year totals are illustrations built on the assumptions stated beside them, not quotes.

We measure first. Then we act.

Know the price before you start. The assessment costs nothing.